Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics.

Villain N, Planche V, Lilamand M, Cordonnier C, Soto-Martin M, Mollion H, Bombois S, Delrieu J, French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies

Open source

DOI: 10.1016/j.tjpad.2025.100094
Published: 2025 Apr
Container: The journal of prevention of Alzheimer's disease
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tjpad.2025.100094,
  title = {Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics.},
  author = {Villain N and Planche V and Lilamand M and Cordonnier C and Soto-Martin M and Mollion H and Bombois S and Delrieu J and French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies},
  year = {2025},
  journal = {The journal of prevention of Alzheimer's disease},
  doi = {10.1016/j.tjpad.2025.100094},
  url = {https://doi.org/10.1016/j.tjpad.2025.100094}
}

RIS

TY  - JOUR
TI  - Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics.
AU  - Villain N
AU  - Planche V
AU  - Lilamand M
AU  - Cordonnier C
AU  - Soto-Martin M
AU  - Mollion H
AU  - Bombois S
AU  - Delrieu J
AU  - French Federation of Memory Clinics Work Group on Anti-Amyloid Immunotherapies
PY  - 2025
JO  - The journal of prevention of Alzheimer's disease
DO  - 10.1016/j.tjpad.2025.100094
UR  - https://doi.org/10.1016/j.tjpad.2025.100094
ER  -

APA

N, V., V, P., M, L., C, C., M, S., H, M., S, B., J, D., & Immunotherapies, F. F. O. M. C. W. G. O. A. (2025). Lecanemab for early Alzheimer's disease: Appropriate use recommendations from the French federation of memory clinics.. The journal of prevention of Alzheimer's disease. https://doi.org/10.1016/j.tjpad.2025.100094

Source records

pubmed · retrieved 2026-09-26T21:22:11.740Z